Providing access to cutting-edge therapies
As part of our commitment to keeping the Central Coast at the forefront of modern cancer care, Ridley-Tree Cancer Center partners with US Oncology Research Network, NRG Oncology Network, TRIO-US Network, and leading pharmaceutical companies and universities to access many clinical trials that deliver the latest treatments science has to offer. Through these networks, we identify and initiate trials based on the science and the need in our community.
Our oncologists work with members of the Clinical Research Department to review patient records and identify those who would benefit from the promising new therapies offered in clinical trials. Additionally, the Cancer Center partners with Tempus Time Trial Network, a technology platform that analyzes molecular and clinical data on cancer patients in real time to find suitable and convenient trials. Through this program, we can accelerate patient enrollment in clinical trials personalized for their molecular and clinical background. Implementation of these studies requires a team of dedicated physician principal investigators, highly trained research coordinators as well as regulatory and data specialists. This team is recognized for their focus on patient safety and personalized care, and they compassionately guide patients through each step of their treatment.
See Open Clinical Trials >
For more information, please contact the Clinical Research department at:
research@ridleytreecc.org
(805) 879-0643
This program is made possible thanks to the generosity of the Cancer Foundation of Santa Barbara, Ridley-Tree Cancer Center’s fundraising partner.
